No Data
ETF midday review | Golden industrial concept leads the gains, golden industrial concept etf funds, golden industrial concept etf rose by 2%, yifangda gem etf surged near midday.
On September 20th, the three major stock indexes of A-shares collectively adjusted in the morning market. As of midday, the Shanghai Composite Index fell 0.23%, the Shenzhen Component Index fell 0.44%, and the ChiNext Price Index fell 0.80%. The turnover in the entire market in the morning session was 347.3 billion yuan, a decrease of 80.5 billion yuan compared to the previous day. Over 3,500 stocks in the two markets declined. In terms of the market, the Huawei industry chain, cybersecurity, innovation and creativity, and real estate sectors have increased the most, while the China Shipbuilding series, photovoltaic equipment, and innovative drug concepts have decreased the most. As for ETFs, the golden industrial concept stocks have increased the most, with ICBC Credit Suisse Fund Golden Industrial Concept ETF, Ping An Fund Gold Industry ETF, and Yongying Fund Golden Industrial Concept ETF all increasing by 2%.
The 300etf saw an inflow of over 20 billion yuan again last week, marking the eleventh consecutive week of significant inflow.
Last week, the non-currency etf scale decreased by 2.081 billion yuan, with a net inflow of 30.834 billion yuan.
ETF market review | The Hong Kong stock innovative drugs sector accelerated its rise in the afternoon, with the Hong Kong stock connect innovative drugs ETF rising by 3%.
On August 26th, the three major indexes of A-shares fluctuated narrowly. As of the close, the Shanghai Composite Index rose by 0.04%, the Shenzhen Component Index rose by 0.16%, and the ChiNext Price Index fell by 0.10%. The total turnover of the Shanghai and Shenzhen stock markets was 526.5 billion yuan, an increase of 16.3 billion yuan from the previous day. Over 3,800 stocks in the two markets rose. In terms of sectors, the battery, western development, and non-ferrous metal sectors performed well, while the foldable screen, AI glasses, and other consumer electronics concept stocks rose. The performance of the expressway, education, and baijiu sectors was weak. As for ETFs, Hong Kong-listed innovative drug stocks rebounded strongly, with Huitianfu Fund's Hong Kong Stock Connect Innovative Drugs ETF and Yinhuayin Fund's Hong Kong Stock Connect Innovative Drugs ETF rising by 3%
ETF review | The afternoon decline in the innovative drugs sector deepened, with Hong Kong stock connect innovative drugs ETF and Hong Kong stock innovative drugs both falling by 2%.
Great Wisdom News August 23rd|A-shares three major indexes fluctuated and rebounded, as of the close, the Shanghai Composite Index rose by 0.20%, the Shenzhen Component Index rose by 0.24%, the ChiNext Price Index rose by 0.02%, and the BCI Index fell by 0.70%. The trading volume of the two cities was 510.2 billion yuan, a decrease of 38.9 billion yuan from the previous day. Over 3200 individual stocks fell in the two markets. On the market, the battery, lithium, and clothing and home textiles sectors saw the largest declines, while the online car-hailing and pharmaceutical sectors declined. The Huawei industry chain surged, and the stocks related to the western development concept rose at the end of the day. As for ETFs, the large financial sector rose, and Huafu Fund Securities ETF Pioneer and E Fund Securities Insurance ETF both rose.
The Hong Kong Stock Innovative Drug ETF rose more than 10% weekly, and the 10 billion fund manager talks about the pharmaceutical industry
Innovative drugs rose. As of 13:20, Yinhua Fund's Hong Kong Stock Innovative Drug ETF had risen more than 2.3%. Huitianfu Fund Hong Kong Stock Connect Innovative Drug ETF, E-Fangda Fund Innovative Drug ETF E-Fangda, Tianhong Fund Innovative Drugs Shanghai-Hong Kong Shenzhen ETF, Guangfa Fund Hong Kong Stock Innovative Drug ETF, Tibet Dongcai Fund Innovative Drug ETF Shanghai, Hong Kong Shenzhen, and Harvest Fund Sci-Tech Biopharmaceutical ETF, Fuguo Fund Innovative Drug ETF Fuguo, E-Fangda Fund Hong Kong Stock Pharmaceutical ETF, Huatai Healthcare Fund ETFs followed suit. The Hong Kong stock market continued to rise this week. Yinhua Fund Hong Kong Stock Innovative Drug ETF, Foreign Exchange
Hong Kong Innovative Drug ETFs and Hang Seng Healthcare ETFs rose as the industry showed positive results
The innovative drug sector boosted. Hong Kong stocks of Tiger Pharmaceuticals rose more than 19%, Zhaoyan Pharmaceutical rose more than 16%, and A-shares of Tiger Pharmaceuticals and Zhaoyan New Pharmaceuticals rose to a standstill. In terms of ETFs, Yinhua Fund Hong Kong Stock Innovative Drug ETF and Guangfa Fund Hong Kong Stock Innovative Drug ETF rose more than 3%; Huitianfu Fund Hong Kong Stock Connect Innovative Drug ETF, Wells Fargo Fund Innovative Drug ETF Fuguo, Huatai Berry Fund Shanghai-Hong Kong-Shenzhen Innovative Drug ETF, China Southern Fund Innovative Drug ETF, ICBC Credit Suisse Fund Innovative Drug Industry ETF, Guangfa Fund Innovative Drug ETF, and CCF Innovative Drug ETF